George W. Sledge
Stanford Medicine(US)Caris Life Sciences (United States)(US)Stanford University(US)
Publications by Year
Research Areas
Cancer Treatment and Pharmacology, Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Advanced Breast Cancer Therapies, Cancer Genomics and Diagnostics
Most-Cited Works
- → Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer(2018)2,319 cited
- → 3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)(2016)2,058 cited
- → MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2− Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy(2017)1,620 cited
- → Prospective Validation of a 21-Gene Expression Assay in Breast Cancer(2015)1,425 cited
- → Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial(2009)1,391 cited
- → Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199(2014)